Microba Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Public

  • Employees
  • 80

Employees

  • Stock Symbol
  • MAP

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.02
  • (As of Friday Closing)

Microba General Information

Description

Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome and engages in providing gut microbiome testing services globally to consumers, clinicians, and researchers. It is also involved in developing new pathology services, therapeutics, and diagnostics based on the human gut microbiome. The company's operating segments are Testing Services and Supplements, which derive key revenue, and Research and Development. Geographically, the company derives maximum revenue from Australia and the rest from Europe, New Zealand, the United States, Asia, and other regions.

Contact Information

Website
www.microba.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • Level 10
  • 324 Queen Street
  • Brisbane, Queensland 4000
  • Australia
+61 1300
Primary Industry
Laboratory Services (Healthcare)
Other Industries
Discovery Tools (Healthcare)
Biotechnology
Stock Exchange
ASX
Vertical(s)
Corporate Office
  • Level 10
  • 324 Queen Street
  • Brisbane, Queensland 4000
  • Australia
+61 1300

Microba Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Microba Stock Performance

As of 13-Nov-2026, Microba’s stock price is $0.02. Its current market cap is $18.2M with 743M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.02 $0.02 $0.02 - $0.07 $18.2M 743M 340K

Microba Financials Summary

As of 30-Sep-2026, Microba has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 30-Jun-2026 FY 2025 30-Jun-2025 FY 2024 30-Jun-2024
EV 21,871 11,339 19,457 29,916
Revenue 9,998 10,138 7,923
EBITDA (11,279) (7,131) (11,832)
Net Income (14,037) (9,666) (13,066)
Total Assets 27,396 30,985 38,794
Total Debt 2,825 2,110 1,057
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Microba Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Microba‘s full profile, request access.

Request a free trial

Microba Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Microba Life Sciences Ltd is a commercial-stage company with technology for measuring the human gut microbiome and engag
Laboratory Services (Healthcare)
Brisbane, Australia
80 As of 2024

New York, NY
 

Boston, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Microba Competitors (26)

One of Microba’s 26 competitors is MeiraGTx, a Formerly VC-backed company based in New York, NY.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
MeiraGTx Formerly VC-backed New York, NY
PureTech Health Formerly VC-backed Boston, MA
Bicycle Therapeutics Formerly VC-backed Cambridge, United Kingdom
Agenus Formerly VC-backed Lexington, MA
Caris Life Sciences Formerly PE-Backed Irving, TX
You’re viewing 5 of 26 competitors. Get the full list »

Microba Patents

Microba Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2018903135-A0 Microbial community profiling method Inactive 24-Aug-2018
AU-2018903134-A0 Profiling method and system Inactive 24-Aug-2018
AU-2018902147-A0 Characterisation method Inactive 15-Jun-2018
WO-2019237158-A1 Methods for sample preparation and microbiome characterisation Inactive 15-Jun-2018 C12Q1/24

Microba Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Microba Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Microba‘s full profile, request access.

Request a free trial

Microba Acquisitions (1)

Microba’s most recent deal was a Merger/Acquisition with Invivo Healthcare for . The deal was made on 05-Dec-2023.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Invivo Healthcare 05-Dec-2023 Merger/Acquisition Biotechnology
To view Microba’s complete acquisitions history, request access »

Microba ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Microba’s complete esg history, request access »

Microba Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Invivo Healthcare Stroud, United Kingdom 2007

Microba FAQs

  • When was Microba founded?

    Microba was founded in 2017.

  • Where is Microba headquartered?

    Microba is headquartered in Brisbane, Australia.

  • What is the size of Microba?

    Microba has 80 total employees.

  • What industry is Microba in?

    Microba’s primary industry is Laboratory Services (Healthcare).

  • Is Microba a private or public company?

    Microba is a Public company.

  • What is Microba’s stock symbol?

    The ticker symbol for Microba is MAP.

  • What is the current stock price of Microba?

    As of 13-Nov-2026 the stock price of Microba is $0.02.

  • What is the current market cap of Microba?

    The current market capitalization of Microba is $18.2M.

  • Who are Microba’s competitors?

    MeiraGTx, PureTech Health, Bicycle Therapeutics, Agenus, and Caris Life Sciences are some of the 26 competitors of Microba.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process